ods due to the great importance of the redox potential for the understanding of the mechanism of biological activity [2] . The title compound shows significant activity against metronidazole-resistant Helicobacter pylori [3] . In the crystal structure, the imidazole ring is a well defined plane with an average deviation of 0.006 A. The nitro Ν atom lies 0.057(3) Ä below the plane. The two other groups attached to the ring are located on the opposite side of the plane, with deviations of C9 and CS atoms from the best plane of -0.011(4) Ä and 0.102(3) Ä, respectively. l-(2-hydroxyethyl)-2-methyl-5-nitroimidazole (metronidazole) [4] crystallizes non-isotypically because of the stronger intermolecular O-H-Ο bonds and only weaker C-H-Br interactions formed in the title structure (apart from N-O-H-C interactions appearing in both structures). 
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Source of material
Mesilatemetronidazole and bromidemetronidazole were prepared as described in the literature [1] . To a dimethylformamide solution (30 ml) of mesilatemetronidazole (453.6 mg, 1.82 mmol) was added NaBr (1872.5 mg, 18.18 mmol). This mixture was stirred for 5 h at 353 K. The solvents were removed and the residue recrystallized from ether. Crystals were collected and washed with diethyl ether added in presence of NaS04-Large crystals suitable for X-ray crystal structure determination were obtained after filtration and drying at room temperature (yield 81 %).
Discussion
Nitroimidazole derivatives are extensively used in the treatment of anaerobic infections and more recently as anti-Helicobacter pylori agents. They are largely studied by electrochemical meth- 
